Form 4: Nuvation Bio Executive Acquires Shares and Stock Options
SEC Form 4
David C. Hanley, Chief Technical Operations Officer of Nuvation Bio, reports acquisition of shares and stock options.
Summary
- David C. Hanley, Chief Technical Operations Officer of Nuvation Bio Inc. [NUVB], filed a Form 4.
- The filing reports a transaction on February 29, 2024.
- Hanley acquired 12,000 shares of Class A Common Stock.
- Hanley also acquired options to purchase 500,000 shares of Class A Common Stock at an exercise price of $1.87.
- The options vest 25% on the one-year anniversary of February 29, 2024, and then monthly over the following 36 months, contingent upon continuous service.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The acquisition of shares and options by an executive suggests confidence, but it's a routine filing.
Positives
- The acquisition of shares and options by a company executive can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about a company's prospects.
Stakeholder Impact
- The reported transactions provide transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| May 19, 2023 | 3,000 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan. |
| November 17, 2023 | 3,000 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan. |
| February 29, 2024 | Date of transaction: acquisition of 12,000 shares and options to purchase 500,000 shares. |
| February 27, 2034 | Expiration date of the stock options. |
| March 04, 2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.